Historical Stock Price
ETFs Holding QCLN »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
12/02/2022 $56.89 $59.03 $56.87 $58.80 107.00K
12/05/2022 $58.56 $58.74 $57.08 $57.32 156.10K
12/06/2022 $57.37 $57.37 $54.36 $54.72 160.00K
12/07/2022 $54.46 $55.49 $54.31 $54.85 125.10K
12/08/2022 $55.12 $55.97 $54.83 $55.25 98.40K
First Trust NYSE Arca Biotechnology Index Fund is an open-end management company. The Fund seeks investment results that correspond generally to the price and yield of an equity index called the NYSE Arca Biotechnology Index (the Index). The Index is an equal dollar-weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. As of Dec 31 2013, the Fund's total assets were $983,610,857 and the Fund's investment portfolio was valued at $969,483,653.
QCLN historical stock prices picture
First Trust Exchange-Traded Fund - NYSE Arca Biotechnology Index Fund (QCLN) has the following price history information. Looking back at QCLN historical stock prices for the last five trading days, on December 02, 2022, QCLN opened at $56.89, traded as high as $59.03 and as low as $56.87, and closed at $58.80. Trading volume was a total of 107.00K shares. On December 05, 2022, QCLN opened at $58.56, traded as high as $58.74 and as low as $57.08, and closed at $57.32. Trading volume was a total of 156.10K shares. On December 06, 2022, QCLN opened at $57.37, traded as high as $57.37 and as low as $54.36, and closed at $54.72. Trading volume was a total of 160.00K shares. On December 07, 2022, QCLN opened at $54.46, traded as high as $55.49 and as low as $54.31, and closed at $54.85. Trading volume was a total of 125.10K shares. On December 08, 2022, QCLN opened at $55.12, traded as high as $55.97 and as low as $54.83, and closed at $55.25. Trading volume was a total of 98.40K shares.

QCLN Historical Stock Prices By Date:

QCLN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into First Trust Exchange-Traded Fund - NYSE Arca Biotechnology Index Fund shares, starting with a $10,000 purchase of QCLN, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 12/11/2012
End date: 12/08/2022
Start price/share: $9.43
End price/share: $55.25
Starting shares: 1,060.45
Ending shares: 1,136.14
Dividends reinvested/share: $1.33
Total return: 527.72%
Average Annual Total Return: 20.17%
Starting investment: $10,000.00
Ending investment: $62,768.53
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/11/2012
End date: 12/08/2022
Start price/share: $9.43
End price/share: $55.25
Dividends collected/share: $1.33
Total return: 500.03%
Average Annual Total Return: 19.63%
Starting investment: $10,000.00
Ending investment: $60,005.05
Years: 10.00
Date Close
12/02/2022$58.80
12/05/2022$57.32
12/06/2022$54.72
12/07/2022$54.85
12/08/2022$55.25
QCLN is categorized under the Financials sector; below are some other companies in the same sector:

QCP Historical Stock Prices
QCRH Historical Stock Prices
QDEF Historical Stock Prices
QDEU Historical Stock Prices
QDF Historical Stock Prices
QDYN Historical Stock Prices
QED Historical Stock Prices
QEFA Historical Stock Prices
QEMM Historical Stock Prices
QESP Historical Stock Prices

Also explore: QCLN shares outstanding history

Email EnvelopeFree QCLN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

QCLN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.